Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists
Statin Use Improves Outcomes in Chronic, Small Lymphocytic Leukemia
Improvements seen in overall survival, progression-free survival, and cancer-specific survival
Psoriatic Arthritis Tied to Delays in Diagnosis Compared With Rheumatoid Arthritis
Patients with psoriatic arthritis are less likely to begin disease-modifying antirheumatic drug therapy
2019 to 2023 Saw Increase in Prevalence of Psilocybin Use in the United States
Increase seen in lifetime use among adults and adolescents; past-year use higher among young adults, older adults
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
Findings seen among 33,995 individuals aged 40 years and older with untreated hypertension
Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia
Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
Neoadjuvant PD-1 blockade with dostarlimab enables nonoperative management strategy for large proportion of patients
FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa
CDC Provides Update on Measles Outbreak in the United States
Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas
